Sugar Derivatives TRIZ Cases

Replacing endogenous mouse CD27 genes with human sequences creates animal models that accurately reflect human disease states and drug interactions.

Universal promoter sequences enable enzyme testing in diverse species without expensive codon optimization or complex cloning workflows.

A near-infrared probe with a self-immolative linker activates fluorescence upon SA-beta-Gal interaction.

A polynucleotide sequencing method uses distinct luminescence forms and timings to distinguish sequential nucleotide incorporation.

Electron withdrawing groups at the 7- or 8-position prevent nitrite-mediated deamination during enzymatic DNA synthesis, enabling longer strands.

Detecting BICD1 gene SNPs identifies myopia susceptibility through genetic marker analysis.

A UDP-glycosyltransferase fusion enzyme converts rebaudioside E into rebaudioside D2.

Glycosylated polyethyleneimine complexes bind PTEN genes for stable aerosol delivery, reducing cytotoxicity and immune responses in lung cancer treatment.

Galactose-modified PCN-224 metal-organic frameworks load doxorubicin for active hepatic targeting via asialoglycoprotein receptor binding.

Profiling transposable element expression resolves diagnostic specificity issues in TDP-43 associated neurodegenerative disorders.

Host cells expressing mammalian VKOR bypass warfarin inhibition of the vitamin K cycle, maintaining carboxylation efficiency for coagulation factors.

Cyclic dithiolane functionalized phosphoramidite derivatives introduce multiple thiol groups to oligonucleotides for strong surface binding.

Performing solid-phase synthesis directly on capillary channels eliminates steric hindrance, enabling longer high-purity polymer chains.

A carbazole-based photoreactive nucleotide enables sequence-selective crosslinking via vinyl group activation.

A C-glycoside derivative inhibits the SGLT2 transporter to lower blood glucose levels.

Disrupting xylitol dehydrogenase in engineered yeast blocks metabolic conversion, resolving low yield and high pollution from chemical reduction methods.

Rigid mesitylene cores with six glucose groups stabilize membrane proteins against denaturation, enabling high-quality crystallization for structural analysis.

Engineered microorganisms produce propylene via integrated fermentation pathways, eliminating fossil fuel dependency and reducing environmental emissions.

Solvent-induced precipitation isolates polyalkoxylated nucleic acids, eliminating expensive chromatographic resins and reducing production time.

Using organic sulfonic acid catalysts for high-pressure dehydration suppresses side reactions and equipment corrosion while maintaining high isosorbide yields.

Proximity oligonucleotides form amplicons upon analyte binding, eliminating spurious signal formation from non-specific interactions.

Targeting elevated microRNA-382 levels under hypoxia, the inhibitor suppresses new blood vessel formation and tumor cell proliferation.

Whole transcriptome sequencing identifies NPM1-TYK2 fusions to overcome insufficient diagnostic precision in CD30-positive lymphoproliferative disorders.

Agroinfection method using TMV vectors with p19 suppressor eliminates complex in vitro transcription while preventing post-transcriptional gene silencing.

Measuring specific microRNA expression levels in granulosa cells diagnoses ovarian dysfunction, addressing low pregnancy success rates from poor response.

Nuclease agents expand genomic repeats at the C9ORF72 locus to generate precise non-human animal models.

Chimeric napin promoters merge native sequences with enhancers to boost fatty acid biosynthesis enzyme levels, reducing saturated fats in transgenic canola.

A molecular beacon kit uses transcription-mediated amplification to detect streptococcal nucleic acids.

Segmented antibody fragments reduce molecular size while maintaining binding specificity, enabling cellular penetration and tumor targeting.

Bonding a specific compound to the substrate prevents degradation, enabling multiple uses and reducing preparation costs.

Aprotic solvent crystallization yields stable crystal form E, resolving poor solubility and reproducibility issues in myocardial perfusion imaging agents.

Truncated adenosine derivatives with specific substituents act as antagonists to selectively inhibit A2A and A3 adenosine receptors.

Macrocyclic backbone constraints enhance nuclease resistance and target specificity while flexible linker regions restore molecular adaptability.

Carbonyl addition reactions improve storage stability and binding efficiency for biomolecule detection.

Succinimide linkers attach STING agonists to antibody cysteine residues, localizing immune activation and reducing systemic cytokine release.

CTPS1 inhibitors target smooth muscle cell proliferation to prevent neointima formation.

A process for preparing 3'-O-amino-ribonucleotides using sulfonylation and hydroxy-aminated derivatives to bypass complex selectivity issues.

Engineered C/D box snoRNAs guide targeted 2′-O-methylation of telomerase RNA, overcoming instability and off-target effects of antisense strategies.

Modified E1A and E1B genes in producer cell lines enable high-yield adenovirus manufacturing while eliminating replication-competent contaminant formation.

Bio-sourced metallo-organic flame retardants resolve health concerns by forming protective char layers through oxidation reactions.

Optimized 20-23 nucleotide sequences improve exon skipping efficiency by targeting the exon 80-intron boundary, addressing low efficacy of prior therapies.

A Tat protein secretion pathway transports folded heterologous proteins across the corynebacterial membrane.

Targeting noncoding transcripts beyond the 3′-UTR extends RNA-mediated regulation boundaries, addressing limited prior investigation into these regions.

Antisense nucleic acid molecules target conserved HIV-1 sequences to suppress viral production while minimizing off-target effects on human RNAs.

An oxygen-regulated promoter controls metabolic flux to redirect carbon sources away from toxic acetate production.

A 1.3 kb Runx2 enhancer activates osteoblast-specific gene expression in transduced cells.